APA

Rautou P., Moucari R., Cazals-Hatem D., Escolano S., Denié C., Douarin L., Francoz C., Durand F., Ozenne V., Imbert A., Moreau R., Lebrec D., Plessier A. & Valla D. (20100107). Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome. : Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Chicago

Rautou Pierre-Emmanuel, Moucari Rami, Cazals-Hatem Dominique, Escolano Sylvie, Denié Cécile, Douarin Ludivine, Francoz Claire, Durand François, Ozenne Violaine, Imbert Audrey, Moreau Richard, Lebrec Didier, Plessier Aurélie and Valla Dominique. 20100107. Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome. : Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Harvard

Rautou P., Moucari R., Cazals-Hatem D., Escolano S., Denié C., Douarin L., Francoz C., Durand F., Ozenne V., Imbert A., Moreau R., Lebrec D., Plessier A. and Valla D. (20100107). Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome. : Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

MLA

Rautou Pierre-Emmanuel, Moucari Rami, Cazals-Hatem Dominique, Escolano Sylvie, Denié Cécile, Douarin Ludivine, Francoz Claire, Durand François, Ozenne Violaine, Imbert Audrey, Moreau Richard, Lebrec Didier, Plessier Aurélie and Valla Dominique. Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome. : Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 20100107.